Work

A Consolidated Overview Of 14 Years Of Global Data From The Transthyretin Amyloidosis Outcomes Survey

Year: 2022

Type: article

Source: Journal of Cardiac Failure

DOI: 10.1016/j.cardfail.2022.03.284

Authors: Angela Dispenzieri, Teresa Coelho, Isabel Conceição, Márcia Waddington-Cruz, Jonas Wixner, Arnt Kristen, Claudio Rapezzi, Violaine Planté-Bordeneuve, Juan Gonzalez-Moreno, Mathew S. Maurer, Martha Grogan, Doug Chapman, Leslie Amass

Institutions: Mayo Clinic, Hospital de Santo António, University of Lisbon, Hospital de Santa Maria, Universidade Federal do Rio de Janeiro, Umeå University, Heidelberg University, University of Ferrara, Maria Cecilia Hospital, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Henri-Mondor, Hospital Son Llatzer, Health Research Institute of the Balearic Islands, Columbia University, Pfizer (United States)

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4225000198

FWCI: 0.082

Cites:

Cited by: 1

Related to: 10